Roberto Sorio
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 54
- Oncology top 1%
- Cancer Treatment and Pharmacology 29
- Lung Cancer Research Studies 14
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 11
-
- Lymphoma Diagnosis and Treatment 13
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 10
-
- Intraperitoneal and Appendiceal Malignancies 17
-
- Cancer therapeutics and mechanisms 13
Roberto Sorio
124 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Reproductive Medicine 1.7k
- Oncology 1.7k
- Obstetrics and Gynecology 403
- Pathology and Forensic Medicine 653
- Cancer Research 533
Countries citing papers authored by Roberto Sorio
This map shows the geographic impact of Roberto Sorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Sorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Sorio more than expected).
Fields of papers citing papers by Roberto Sorio
This network shows the impact of papers produced by Roberto Sorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Sorio. The network helps show where Roberto Sorio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roberto Sorio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2022 | 8 | |
| 3 | 2020 | 18 | |
| 4 | 2019 | 27 | |
| 5 | 2019 | 8 | |
| 6 | 2018 | 14 | |
| 7 | 2015 | 17 | |
| 8 | Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trialbreakdown → | 2014 | 1117 |
| 9 | 2014 | 20 | |
| 10 | 2012 | 4 | |
| 11 | 2004 | 10 | |
| 12 | Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT. | 2003 | 12 |
| 13 | 2003 | 6 | |
| 14 | 1999 | 4 | |
| 15 | 1994 | 19 | |
| 16 | 1994 | 18 | |
| 17 | 1991 | 6 | |
| 18 | 1990 | 2 | |
| 19 | 1990 | 6 | |
| 20 | 1986 | 4 |
About Roberto Sorio
Roberto Sorio is a scholar working on Reproductive Medicine, Oncology, Obstetrics and Gynecology, Pathology and Forensic Medicine and Cancer Research, having authored 129 papers that have together received 3.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (54 papers), Cancer Treatment and Pharmacology (29 papers), Intraperitoneal and Appendiceal Malignancies (17 papers), Lung Cancer Research Studies (14 papers), Lymphoma Diagnosis and Treatment (13 papers), Cancer therapeutics and mechanisms (13 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Reproductive Medicine (1.7k citations), Oncology (1.7k citations), Obstetrics and Gynecology (403 citations), Pathology and Forensic Medicine (653 citations) and Cancer Research (533 citations). Roberto Sorio has collaborated with scholars based in Italy, France and Belgium. Frequent co-authors include Éric Pujade-Lauraine, Felix Hilpert, Mansoor Raza Mirza, Gunnar B. Kristensen, Pauline Wimberger, B. Weber, Ignace Vergote, Petronella O. Witteveen, Andrés Poveda and Ana Oaknin. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Chemotherapy and Pharmacology, Gynecologic Oncology and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.